Anti-PD-1/PD-L1 Antibodies Plus Pegylated Interferon Alfa-2b Treatment in Patients With Advanced-Stage HCC
Clinical trial NCT04943679 · UNKNOWN
Trial details
- NCT number
- NCT04943679
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-06-15
- Primary completion
- 2024-12-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.